Nadege Briancon-Eris

Nadege Briancon-Eris has extensive work experience in program management and operations, primarily in the pharmaceutical industry. In their current role as the Executive Director of Program Management and Chief of Staff to the CMO at Abivax, they oversee program management and provides support to the CMO. Prior to this, they worked as a Senior Director of Program Management at CinCor Pharma, where they played a key role in the acquisition of the company by AZ. Nadege also served as the Director of Program Management and Operations at Astellas Pharma US. Additionally, Nadege has held various program management roles at Corvidia Therapeutics, Novo Nordisk, and Moderna Therapeutics, where they managed and led programs related to cardiovascular and metabolic diseases. Nadege also has experience as a reviewer at the open-access journal PLOS ONE. Nadege's academic background includes postdoctoral research positions at Harvard Medical School and Beth Israel Deaconess Medical Center, as well as a researcher Ph.D. student role at Institut Pasteur.

Nadege Briancon-Eris earned a Magistere degree in Molecular and Cellular Biology from École normale supérieure de Lyon in 2000, and later completed a PhD in Genetics from Pierre and Marie Curie University between 2000 and 2005.